53 parallel-and-distributed-computing-"UNIS"-"Meta"-"Humboldt-Stiftung-Foundation" positions at VIB
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Description We are seeking a motivated new PhD candidate who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between the Guilliams and
-
fundamental research and a strong emphasis on innovation and business development. VIB is deeply committed to driving the growth of the thriving life sciences cluster in Flanders. The VIB Technologies program
-
Description We are seeking a motivated new PhD candidate or Postdoctoral Fellow who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between
-
Description We are seeking a motivated new PhD candidate who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between the Guilliams, Saelens
-
independently. Proficient in using computer software. Enthusiastic, social, and possessing excellent communication skills (English proficiency required). Eager to acquire new skills in biochemistry
-
research that offers real-world solutions to citizens, patients, and farmers. Beyond research, VIB is dedicated to fostering knowledge-sharing through the Training & Conferences Program, offering a range of
-
infrastructure of the institute, provides scientists with access to cutting-edge technologies. The program comprises the Tech Watch Core and 11 state-of-the-art core facilities, supporting the institute’s 1900
-
Description We are seeking a motivated new PhD candidate or Postdoctoral fellow who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between
-
universities in Flanders, we drive innovation and scientific discovery in areas like biotechnology, genomics, and computational biology. The VIB Data Core is a key enabler of this mission, providing cutting-edge
-
based on research conducted by VIB PIs. Focus will be on human therapeutics, drug development, including novel drug modalities, novel technologies and in silico/computational approaches. Familiarize